Navigation Links
deCODE genetics Announces Third Quarter 2008 Financial Results
Date:11/6/2008

ed. First and second generation PDE4 inhibitors such as rolipram,

cilomilast, and roflumilast caused significant side effects, including

nausea and vomiting, at therapeutic doses in human clinical trials.

Data generated at deCODE suggest that the observed side effects were

closely correlated with the binding of these molecules in the PDE4

enzymatic active site competitively with cAMP. As cAMP is of critical

importance to neuronal signaling, the goal of deCODE's program has been

to discover compounds that would modulate PDE4 activity via an

allosteric mechanism to improve safety and tolerability. Towards this

goal, the decode biostructures team solved multiple novel co-crystal

structures of PDE4D & PDE4B containing regulatory domains with bound

ligands. Those structures allowed the deCODE chemistry team to identify

a novel binding site for allosteric modulators in the PDE4 regulatory

domain. In animal models, DG071 has been shown to significantly improve

learning and long- and short-term memory at doses that offer a wide

margin for safety and tolerability.

- deCODE Breast Cancer. In October, deCODE launched deCODE

BreastCancer(TM), the company's latest DNA-based disease risk test, for

assessing individual risk of the common forms of breast cancer and

personalizing screening and treatment strategies. The seven markers

measured by the test, discovered by deCODE and others, contribute to

the incidence of an estimated 60 percent of all breast cancers. The

test integrates data from discovery and replication studies published

in major peer-reviewed journals and involving nearly 100,000 breast

cancer patients and healthy volunteers from many populations. The test

can identify the roughly 5 percent of women who are at a greater than

20 percent lifetime risk of the common
'/>"/>

SOURCE deCODE genetics Inc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Annual Healthcare Conference
2. deCODE genetics Announces Webcast of Conference Call to Discuss Third Quarter 2007 Financial Results
3. deCODE genetics Announces Third Quarter 2007 Financial Results
4. deCODE Launches deCODEme(TM)
5. deCODE genetics to Webcast Presentation at JPMorgan Annual Healthcare Conference
6. deCODE Discovers Gene Variants that May Help to Distribute the Work of Evolution between Men and Women
7. deCODE genetics to Webcast Presentation at BIO CEO and Investor Conference
8. deCODE genetics Announces Webcast of Conference Call to Discuss Full-year 2007 Financial Results
9. deCODE Genetics Announces Full-year 2007 Financial Results
10. deCODE genetics to Webcast Presentation at Lehman Brothers Eleventh Annual Global Healthcare Conference
11. deCODE genetics to Webcast Presentation at 15th Annual Future Leaders in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... Israel , September 2, 2015 ... intent of the National Institute of Allergy and Infectious Diseases ... within the Department of Health and Human Services (HHS), to ... the United States in the 2015-16 ... flu vaccine candidate, Multimeric-001 (M-001), as a primer vaccine, which ...
(Date:9/2/2015)... Diego, CA (PRWEB) , ... September 02, 2015 ... ... troubleshooting faults in manufacturing equipment, to creating professional commercial video content, to analysis ... detailed views of fascinating events that go by too quickly to process with ...
(Date:9/1/2015)... EDISON, N.J. , Sept. 1, 2015  ContraVir ... focused on the development and commercialization of targeted antiviral ... Rodman & Renshaw 17 th Annual Global Investment ... taking place September 8-10, 2015 at The St. Regis ... James Sapirstein , Chief Executive ...
(Date:9/1/2015)... ... 01, 2015 , ... VetStem Biopharma announces new Clinical Research ... problems can be caused by injuries and abnormalities of the cervical spine. Arthritic ... of the spinal cord itself. This can manifest itself as any or all ...
Breaking Biology Technology:BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 2Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 3ContraVir to Present at Rodman & Renshaw 17th Annual Global Investment Conference 2VetStem Biopharma Announces New Clinical Research Program for Equine Cervical Facet Joint Disease 2VetStem Biopharma Announces New Clinical Research Program for Equine Cervical Facet Joint Disease 3
... 19 Soligenix, Inc. (OTC Bulletin Board: SNGX) ... today that the United States Patent Office (USPTO) has ... Bowel Syndrome and Related Bowel Diseases." The patent claims ... bowel syndrome (IBS), a painful gastrointestinal condition that affects ...
... Troy, N.Y. Researchers from Rensselaer Polytechnic Institute have ... boost the strength of infrared imaging and could lead ... night-vision devices. By leveraging the unique properties of ... the surface of the device, the researchers have doubled ...
... CHAPEL HILL, N.C. , May 18 ... part of educating the marketplace on new medicines. Effectively ... public on treatment options and is especially critical for ... to Educate the Marketplace " is a 125-page report ...
Cached Biology Technology:Soligenix Announces Grant of US Patent for the Treatment of Irritable Bowel Syndrome with Oral Beclomethasone Dipropionate 2Soligenix Announces Grant of US Patent for the Treatment of Irritable Bowel Syndrome with Oral Beclomethasone Dipropionate 3Soligenix Announces Grant of US Patent for the Treatment of Irritable Bowel Syndrome with Oral Beclomethasone Dipropionate 4Soligenix Announces Grant of US Patent for the Treatment of Irritable Bowel Syndrome with Oral Beclomethasone Dipropionate 5Soligenix Announces Grant of US Patent for the Treatment of Irritable Bowel Syndrome with Oral Beclomethasone Dipropionate 6Nanotech discovery at Rensselaer could lead to breakthrough in infrared satellite imaging technology 2Nanotech discovery at Rensselaer could lead to breakthrough in infrared satellite imaging technology 3Educating the Marketplace Through Collaborations with Patient Advocacy Groups 2Educating the Marketplace Through Collaborations with Patient Advocacy Groups 3
(Date:8/24/2015)... 24, 2015 The consulting company Frost ... biometrics manufacturer DERMALOG and its customized solutions and products for ... Company of the Year Award". DERMALOG is particularly successful with ...   -Cross reference: Picture is available at AP ... On Thursday evening, in South Africa,s ...
(Date:8/19/2015)... , Aug. 19, 2015  VOXX International ... it has entered into a Definitive Agreement to ... of iris authentication market leader EyeLock through an ... will have a controlling interest in the acquiring ... to completion of due diligence.  Expanding on its ...
(Date:8/12/2015)... 12, 2015 As the digital ... innovation and advanced biometrics technology is accelerating beyond expectations.  ... rely on using their credit cards, the digital currency, ... for payment services led by companies in the space ... Google, Inc. (NASDAQ: GOOG ), Apple Inc. (NASDAQ: ...
Breaking Biology News(10 mins):Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 2Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 2Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 3Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 4Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 5Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 6
... Burgess Shale of British Columbia is arguably the most ... record of the Cambrian "Explosion," the rapid flowering of ... fossil record is comprised of shells, teeth and bones, ... gills and other delicate structuresof animals belonging to Earth,s ...
... of studying two experimental wetlands has convinced Bill Mitsch that ... sense when it comes to this area of ecological restoration. ... State University, has led the effort to compare the behavior ... planted in 1994 with wetland vegetation and another that was ...
... ready?" asks Dr. Changlu Wang, Rutgers University entomologist and ... Management symposium. Bed bugs have become problematic pests of ... bed bug researchers and educators will discuss innovative bed ... and educators in a symposium to be held on ...
Cached Biology News:Mechanism for Burgess Shale-type preservation 215-year study: When it comes to creating wetlands, Mother Nature is in charge 215-year study: When it comes to creating wetlands, Mother Nature is in charge 315-year study: When it comes to creating wetlands, Mother Nature is in charge 4Bed bugs, stink bugs headline Entomology Meeting in Hartford, Conn. 2
Identify and characterize Phosphoinositide (PI(4,5)P2) binding...
... These skirted micro test tubes are used ... polypropylene, these tubes have uniform walls for ... with separate O-ring screw caps. The O-rings ... have an operating range from -55 to ...
... Sac-Cel (Second Antibody Coated CELlulose) was developed ... of Dartford, Kent, one of the earliest ... IDS acquired the product range in 1987. ... clinical biochemists developing their own "in house" ...
Determine relative degree of protein binding to phosphoinositides...
Biology Products: